Szostak Nobel prize in medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Jack Szostak | Courtesy of Massachusetts General Hospital

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

Harvard Graduate Workers Begin Strike

In the second walkout in six months, union leaders call for better pay and benefits and a stronger grievance process.

Harvard Law School Announces $31.4 Million Donation

The school’s largest-ever gift comes after a year of record fundraising.

Harvard College Applications Surge 15 Percent

Of 1,648 students in the class of 2030, 39 percent will pay no tuition.

Most popular

Keri Russell Calls ‘The Diplomat’ a Love Letter to Public Servants

A Harvard Kennedy School event looks behind the scenes of the Netflix drama. 

The Year a Beat Poet Squatted at Harvard

In 1954, Gregory Corso moved into Eliot House. How he stayed there is a literary legend.

How Philosophy at Harvard Saved Itself

As humanities shrink across higher education, one department is flourishing. Is its success a fluke, or a roadmap?

Explore More From Current Issue

Collage of three photos of an athlete in a triathlon: one swimming, one cycling, one running, in sports attire.

The Harvard triathlete and coach says she helps normal people to “do extraordinary things.”

A girl in blue boots stands on a cliff, holding a leash attached to a glowing, digital dog.

Establishing legal responsibility for autonomous agents

Black and white portrait of a woman with medium-length hair, smiling softly.

The outgoing executive director and Harvard Business School graduate went from dancing The Nutcracker to growing a ballet company.